| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.13.8.1218 |
| P698 | PubMed publication ID | 8343497 |
| P2093 | author name string | R. Ross | |
| M. A. Reidy | |||
| C. L. Jackson | |||
| E. W. Raines | |||
| P433 | issue | 8 | |
| P921 | main subject | cell migration | Q189092 |
| P304 | page(s) | 1218–1226 | |
| P577 | publication date | 1993-08-01 | |
| P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
| P1476 | title | Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury | |
| P478 | volume | 13 |
| Q50751294 | A biochemical and mechanical model of injury-induced intimal thickening. |
| Q73667824 | An association between fibrinolytic activity and graft function in kidney transplantation recipients |
| Q35194484 | Anatomic closure of the premature patent ductus arteriosus: The role of CD14+/CD163+ mononuclear cells and VEGF in neointimal mound formation |
| Q46839240 | Antioxidant activity of caffeoyl-prolyl-histidine amide and its effects on PDGF-induced proliferation of vascular smooth muscle cells |
| Q35829683 | Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice |
| Q24318760 | Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase |
| Q38550385 | Arterial uptake of biodegradable nanoparticles for intravascular local drug delivery: results with an acute dog model |
| Q36330155 | Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway |
| Q78319598 | Biochemical analysis of collagen and elastin synthesis in the balloon injured rat carotid artery |
| Q35789286 | Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice |
| Q35627738 | Characterization of Pdgfrb-Cre transgenic mice reveals reduction of ROSA26 reporter activity in remodeling arteries |
| Q35791966 | Chimera analysis supports a predominant role of PDGFRbeta in promoting smooth-muscle cell chemotaxis after arterial injury |
| Q28658459 | Decorin mimic regulates platelet-derived growth factor and interferon-γ stimulation of vascular smooth muscle cells |
| Q41141172 | Differentiated properties and proliferation of arterial smooth muscle cells in culture. |
| Q24306656 | Disruption of platelet-derived growth factor-dependent phosphatidylinositol 3-kinase and phospholipase Cγ 1 activity abolishes vascular smooth muscle cell proliferation and migration and attenuates neointima formation in vivo |
| Q53669737 | Down-regulation of the ERK1 and ERK2 mitogen-activated protein kinases using antisense oligonucleotides inhibits intimal hyperplasia in a porcine model of coronary balloon angioplasty. |
| Q43631836 | Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle cells |
| Q78023011 | Effects and mechanism of tissue-type plasminogen activator and plasminogen activator inhibitor on vascular smooth muscle cell proliferation |
| Q31886491 | Effects of probucol on rat carotid artery responses to balloon catheter injury |
| Q41185529 | Eicosanoids, fatty acids and restenosis following coronary artery bypass graft surgery and balloon angioplasty |
| Q36176901 | Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation |
| Q37447644 | Endothelial and smooth muscle-derived neuropilin-like protein regulates platelet-derived growth factor signaling in human vascular smooth muscle cells by modulating receptor ubiquitination |
| Q55066900 | Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. |
| Q35774287 | Estradiol attenuates directed migration of vascular smooth muscle cells in vitro |
| Q36832265 | Expression of platelet derived growth factor B chain and beta receptor in human coronary arteries after percutaneous transluminal coronary angioplasty: an immunohistochemical study |
| Q74300252 | High potassium intake inhibits neointima formation in the rat carotid artery balloon injury model |
| Q74436249 | Human monocyte-endothelial cell interaction induces platelet-derived growth factor expression |
| Q92782298 | Hypermethylation of mitochondrial DNA in vascular smooth muscle cells impairs cell contractility |
| Q73681235 | Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery Disease |
| Q35774099 | Identification of platelet-derived growth factor A and B chains in human renal vascular rejection |
| Q39776706 | Impaired arterial neointima formation in mice with disruption of the plasminogen gene |
| Q26863422 | Implications of autophagy for vascular smooth muscle cell function and plasticity |
| Q42049615 | In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty |
| Q42582634 | Increasing our IQ of vascular smooth muscle cell migration with IQGAP1. Focus on "IQGAP1 links PDGF receptor-β signal to focal adhesions involved in vascular smooth muscle cell migration: role in neointimal formation after vascular injury". |
| Q36976632 | Induction of vascular atrophy as a novel approach to treating restenosis. A review |
| Q53224673 | Inhibited proliferation of human umbilical artery smooth muscle cells by xanthinol nicotinate. |
| Q41500641 | Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system. |
| Q73681240 | Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator |
| Q77475569 | Local arterial responses to 32P beta-emitting stents |
| Q41722548 | Matrix metalloproteinases and coronary artery disease: a novel therapeutic target |
| Q73477657 | Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells |
| Q41740450 | Mechanisms of neointima formation--lessons from experimental models |
| Q37331731 | Mitochondrial fission induced by platelet-derived growth factor regulates vascular smooth muscle cell bioenergetics and cell proliferation. |
| Q38991475 | Modulation of Systemic Metabolism by MMP-2: From MMP-2 Deficiency in Mice to MMP-2 Deficiency in Patients |
| Q30441514 | Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells |
| Q75243179 | Neointima formation and thrombosis after vascular injury in transgenic mice overexpressing plasminogen activator inhibitor-1 (PAI-1) |
| Q33696216 | PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress |
| Q33845001 | Pathological effects of pulmonary vein beta-radiation in a swine model. |
| Q34405720 | Pharmacologic inhibition of nitric oxide synthases and cyclooxygenases enhances intimal hyperplasia in balloon-injured rat carotid arteries |
| Q71729475 | Phenotypic modulation of smooth muscle cells during the formation of neointimal thickenings in the rat carotid artery after balloon injury: an electron-microscopic and stereological study |
| Q38313336 | Phosphorothioate Oligodeoxynucleotide Inhibition of Restenosis |
| Q40406453 | Physiological consequences of over- or under-expression of fibrinolytic system components in transgenic mice |
| Q77716498 | Platelet aggregation and platelet-derived growth factor inhibition for prevention of insufficiency of the transjugular intrahepatic portosystemic shunt: a randomized study comparing trapidil plus ticlopidine with heparin treatment |
| Q43715868 | Platelet-derived growth factor inhibits smooth muscle cell adhesion to fibronectin by ERK-dependent and ERK-independent pathways. |
| Q41469674 | Platelet-derived growth factor: a key regulator of connective tissue cells in embryogenesis and pathogenesis |
| Q36885396 | Potential Role of Axonal Chemorepellent Slit2 in Modulating Adventitial Inflammation in a Rat Carotid Artery Balloon Injury Model. |
| Q33690103 | Redox control of vascular smooth muscle migration |
| Q43666441 | Regulation of Raf by Akt controls growth and differentiation in vascular smooth muscle cells |
| Q74094220 | Regulators of fibrynolysis in plasma of kidney transplant recipients |
| Q34992542 | Restenosis after balloon angioplasty and/or stent insertion - origin and prevention |
| Q90720241 | Semaphorin-3A protects against neointimal hyperplasia after vascular injury |
| Q50089075 | Semaphorin-3E attenuates neointimal formation via suppressing VSMCs migration and proliferation |
| Q37357738 | Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides |
| Q41500587 | Signal transduction for PDGF-induced chemotaxis of vascular smooth muscle cells |
| Q40394633 | Signal transduction to mitochondrial ATP synthase: evidence that PDGF-dependent phosphorylation of the delta-subunit occurs in several cell lines, involves tyrosine, and is modulated by lysophosphatidic acid |
| Q38112038 | Smooth muscle cell hypertrophy, proliferation, migration and apoptosis in pulmonary hypertension |
| Q73539176 | Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis |
| Q52764667 | Smooth muscle cells of human veins show an increased response to injury at valve sites. |
| Q41721738 | Smooth muscle migration in vascular development and pathogenesis |
| Q43232811 | Stent-based release of a selective PDGF-receptor blocker from the bis-indolylmethanon class inhibits restenosis in the rabbit animal model |
| Q73286951 | Substantial inhibition of neo-intimal response to balloon injury in the rat carotid artery using a combination of antibodies to platelet-derived growth factor-BB and basic fibroblast growth factor |
| Q36007499 | Suppression of activation of signal transducer and activator of transcription-5B signaling in the vessel wall reduces balloon injury-induced neointima formation |
| Q42102932 | Syndecan-1: an inhibitor of arterial smooth muscle cell growth and intimal hyperplasia |
| Q74810038 | The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration |
| Q28360490 | The discoidin domain receptor tyrosine kinase DDR1 in arterial wound repair |
| Q35221544 | The matricellular protein Cyr61 is a key mediator of platelet-derived growth factor-induced cell migration |
| Q24629974 | The response-to-retention hypothesis of early atherogenesis |
| Q73515090 | The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells |
| Q77924135 | The urokinase receptor mediates basic fibroblast growth factor-dependent smooth muscle cell migration through baboon aortic explants |
| Q24669720 | Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury |
| Q63915546 | Urokinase and tissue-type plasminogen activator stimulate human vascular smooth muscle cell migration |
| Q74547550 | Vascular endothelial growth factor (VEGF) expression during arterial repair in the pig |
| Q35764669 | Vascular wound healing and neointima formation induced by perivascular electric injury in mice. |
Search more.